# China NMPA Inspection - National Medical Products Administration - November 29, 2021

Source: https://www.globalkeysolutions.net/records/china_inspection/national-medical-products-administration/0d412c24-3cf7-472d-a984-2e14826f1ace/
Source feed: China

> China NMPA unannounced inspection for National Medical Products Administration published November 29, 2021. The provided document content is an informational header for a 'Summary Table of Cosmetics Supervision and Inspection Information' compiled by the Fir

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Summary Table of Cosmetic Supervision and Inspection Information from the First Branch of Anhui Provincial Drug Administration (November 2021)
- Company Name: National Medical Products Administration
- Publication Date: 2021-11-29
- Product Type: cosmetics
- Summary: The provided document content is an informational header for a 'Summary Table of Cosmetics Supervision and Inspection Information' compiled by the First Branch of the Anhui Provincial Drug Administration, a regional regulatory body operating under the National Medical Products Administration (NMPA) of China. This summary table pertains to supervisory and inspection activities conducted during November 2021, with its publication dated November 29, 2021, on the official website of the Anhui Provincial Drug Administration. While the document identifies the issuing authority, the subject area (cosmetics supervision and inspection), and the reporting period, it crucially lacks the specific details required for a comprehensive summary of an inspection event. The provided text functions purely as an index entry or metadata description for an underlying report. Consequently, it does not disclose the name of any specific company or entity that was subject to inspection, precise inspection dates beyond the month of November, any identified main violations or issues, or the regulatory framework applied to specific cases other than the general context of cosmetics supervision. Furthermore, no required actions or corrective measures stemming from any inspections are detailed within this introductory content. To provide a complete summary encompassing these critical elements, the full inspection report or the 'Summary Table' document itself would be necessary.

Company: https://www.globalkeysolutions.net/companies/national-medical-products-administration/6e6c9c0b-c8e5-4330-aec0-ab84e891e2fd/